| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPHEART.00379.2008 |
| P8608 | Fatcat ID | release_c5hvasrgcbd3zl2cap7h5h24hy |
| P932 | PMC publication ID | 2759460 |
| P698 | PubMed publication ID | 18689499 |
| P5875 | ResearchGate publication ID | 23158258 |
| P50 | author | Bijan Ghaleh | Q57596191 |
| Sandrine Pons | Q59209356 | ||
| P2093 | author name string | Alain Berdeaux | |
| Roland Zini | |||
| Richard Souktani | |||
| Omar Bouhidel | |||
| P2860 | cites work | Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway | Q44970377 |
| Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. | Q45036450 | ||
| Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation | Q45198263 | ||
| Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. | Q46529109 | ||
| Preconditioning the diabetic heart: the importance of Akt phosphorylation | Q46620654 | ||
| Inhibition of phosphatase activity enhances preconditioning and limits cell death in the ischemic/reperfused aged rat heart | Q46649199 | ||
| Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity | Q46687753 | ||
| Postconditioning the human heart | Q46722557 | ||
| PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning | Q46801102 | ||
| The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits | Q46867340 | ||
| Differential effects of postconditioning on myocardial stunning and infarction: a study in conscious dogs and anesthetized rabbits | Q50093917 | ||
| 5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. | Q50337113 | ||
| Protection from post-conditioning depends on the number of short ischemic insults in anesthetized pigs. | Q50478136 | ||
| Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. | Q54578923 | ||
| Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart | Q78117528 | ||
| Postconditioning in rats and mice | Q79374331 | ||
| Postconditioning protects human atrial muscle through the activation of the RISK pathway | Q80423743 | ||
| Postconditioning inhibits mitochondrial permeability transition | Q81252248 | ||
| Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice | Q81514899 | ||
| No loss of cardioprotection by postconditioning in connexin 43-deficient mice | Q82988104 | ||
| The regulation of AMP-activated protein kinase by phosphorylation | Q24531917 | ||
| Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association | Q27620298 | ||
| Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning | Q28187266 | ||
| Myocardial infarction and remodeling in mice: effect of reperfusion | Q33178763 | ||
| Dual specificity phosphatases: a gene family for control of MAP kinase function. | Q33812365 | ||
| Leptin | Q33904994 | ||
| H11 kinase is a novel mediator of myocardial hypertrophy in vivo | Q34161376 | ||
| New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway | Q34298555 | ||
| Myocardial reperfusion injury. | Q34687124 | ||
| Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects | Q35119948 | ||
| AMP-activated protein kinase: the guardian of cardiac energy status. | Q35864861 | ||
| Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. | Q37019662 | ||
| Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min. | Q37089261 | ||
| AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury | Q37286204 | ||
| Inflammatory and injury responses to ischemic stroke in obese mice | Q38294021 | ||
| Obesity--a risk factor or a RISK factor for myocardial infarction? | Q38961258 | ||
| Aging mouse hearts are refractory to infarct size reduction with post-conditioning | Q39321486 | ||
| 'Postconditioning' the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection | Q39340866 | ||
| Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. | Q40265810 | ||
| Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. | Q40480010 | ||
| Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha | Q42022540 | ||
| Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine | Q42659284 | ||
| Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion | Q44801107 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P304 | page(s) | H1580-6 | |
| P577 | publication date | 2008-08-08 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice | |
| P478 | volume | 295 |
| Q38039283 | AMP-activated protein kinase regulation and biological actions in the heart |
| Q36298488 | Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning |
| Q38125624 | Adiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning |
| Q37225314 | Adipose tissue: a motor for the inflammation associated with obesity |
| Q94054456 | Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes |
| Q36239967 | Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury |
| Q41888649 | Autophagy is involved in the cardioprotection effect of remote limb ischemic postconditioning on myocardial ischemia/reperfusion injury in normal mice, but not diabetic mice |
| Q37999635 | Autophagy, myocardial protection, and the metabolic syndrome. |
| Q38191658 | Cardiomyocyte changes in the metabolic syndrome and implications for endogeneous protective strategies |
| Q49046559 | Cardioprotection by ischemic postconditioning is abolished in depressed rats: role of Akt and signal transducer and activator of transcription-3 |
| Q39284051 | Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes |
| Q35090566 | Cardiovascular remodelling in coronary artery disease and heart failure |
| Q55724095 | Combination of Vildagliptin and Ischemic Postconditioning in Diabetic Hearts as a Working Strategy to Reduce Myocardial Reperfusion Injury by Restoring Mitochondrial Function and Autophagic Activity. |
| Q39529407 | Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats |
| Q39151222 | Delta Opioid Receptors and Cardioprotection. |
| Q33791969 | Developmental programming resulting from maternal obesity in mice: effects on myocardial ischaemia-reperfusion injury |
| Q30457504 | Diabetic cardiomyopathy: pathophysiology and clinical features |
| Q55071504 | Differential PI3K signal transduction in obesity-associated cardiac hypertrophy and response to ischemia. |
| Q37139586 | Discordant signaling and autophagy response to fasting in hearts of obese mice: Implications for ischemia tolerance |
| Q47188296 | Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin |
| Q36288965 | Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning |
| Q54509587 | Effects of the AMP-activated protein kinase inhibitor compound C on the postconditioned rat heart. |
| Q37871976 | Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum |
| Q37247591 | Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo |
| Q33948647 | High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury |
| Q27318055 | Impact of Diet-Induced Obesity and Testosterone Deficiency on the Cardiovascular System: A Novel Rodent Model Representative of Males with Testosterone-Deficient Metabolic Syndrome (TDMetS) |
| Q40630534 | Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effects |
| Q37028671 | Importance of leptin signaling and signal transducer and activator of transcription-3 activation in mediating the cardiac hypertrophy associated with obesity |
| Q41995619 | Influence of cardiovascular risk factors on infarct size and interaction with mechanical ischaemic postconditioning in ST-elevation myocardial infarction. |
| Q36355264 | Influence of tumour necrosis factor alpha on the outcome of ischaemic postconditioning in the presence of obesity and diabetes |
| Q44409387 | Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1. |
| Q37330288 | Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms. |
| Q57809365 | Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trial |
| Q51373653 | Involvement of energetic metabolism in the effects of ischemic postconditioning on the ischemic-reperfused heart of fed and fasted rats. |
| Q38192849 | Ischaemic conditioning strategies for the nephrologist: a promise lost in translation? |
| Q27000466 | Ischaemic conditioning: pitfalls on the path to clinical translation |
| Q26853129 | Ischaemic postconditioning: cardiac protection after the event |
| Q38683468 | Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus |
| Q34457775 | Ischemic conditioning: the challenge of protecting the diabetic heart |
| Q37428292 | Leptin signaling in the failing and mechanically unloaded human heart |
| Q33824028 | Long-term protection and mechanism of pacing-induced postconditioning in the heart |
| Q45145219 | Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance. |
| Q36311333 | Myocardial susceptibility to ischaemia/reperfusion in obesity: a re-evaluation of the effects of age. |
| Q46034115 | Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection. |
| Q36683077 | Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats. |
| Q35286353 | Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart |
| Q47278869 | Ovariectomy reinstates the infarct size-limiting effect of postconditioning in female rabbits. |
| Q38311837 | Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system. |
| Q47388835 | Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner |
| Q37744271 | Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology |
| Q56534241 | Postconditioning promotes the cardiac repair through balancing collagen degradation and synthesis after myocardial infarction in rats |
| Q37240955 | Protective ischaemia in patients: preconditioning and postconditioning |
| Q101476377 | Reduced effect of ischemic preconditioning against endothelial ischemia-reperfusion injury with cardiovascular risk factors in humans |
| Q38319645 | Regular treadmill exercise restores cardioprotective signaling pathways in obese mice independently from improvement in associated co-morbidities. |
| Q28078462 | Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration |
| Q52663456 | Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication. |
| Q42058398 | Role of Tissue and Systemic Hypoxia in Obesity and Type 2 Diabetes. |
| Q38256778 | Roles of obese-insulin resistance and anti-diabetic drugs on the heart with ischemia-reperfusion injury |
| Q38903618 | Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts. |
| Q58707681 | The Mitochondrial Translocator Protein and the Emerging Link Between Oxidative Stress and Arrhythmias in the Diabetic Heart |
| Q34637342 | The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities |
| Q43477300 | The role of the inhibition of glutathione-S-transferase in the protective mechanisms of ischemic postconditioning |
| Q51283489 | The role of α1-adrenergic receptors in regulating metabolism: increased glucose tolerance, leptin secretion and lipid oxidation. |
| Q33948666 | Type 2 diabetic obese db/db mice are refractory to myocardial ischaemic post-conditioning in vivo: potential role for Hsp20, F1-ATPase δ and Echs1 |
| Q31132643 | Unique transcriptional profile of sustained ligand-activated preconditioning in pre- and post-ischemic myocardium |
Search more.